首页 > 最新文献

Research in Cardiovascular Medicine最新文献

英文 中文
Impact of registry implementation on the management and survival of patients with pulmonary embolism 登记实施对肺栓塞患者管理和生存的影响
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-04-01 DOI: 10.4103/rcm.rcm_4_21
O. Shafe, J. Moosavi, A. Alizadehasl, H. Pouraliakbar, B. Naghavi, Sepehr Jamalkhani, Sajjad Rezaei, K. Rezaei-Kalantari, Melody Farrashi, M. Naghshbandi, Parham Rabiei, M. Maleki, H. Talakoob, Maryam Salehi, M. Malakouti, Parham Sadeghipour
Background: Pulmonary embolism (PE) is a major public health concern, with a considerable mortality rate. In the present study, we have evaluated the impact of registry implementation on PE management. Methods: In the present single-center study, composed of two distinct cohorts, we have evaluated the impact of registry implementation (prospective arm-September 2015 to August 2018) on patient management and survival, and compared it with the same duration when no registry was implied (retrospective arm-September 2012 to August 2015). Results: One hundred and seventy and 182 patients were recruited in the prospective and retrospective arms, respectively. Guideline-recommended risk stratification was significantly overlooked before the introduction of PE registry (100% vs. 45.6% prospective and retrospective arms, respectively [P < 0.001]). A trend toward higher administration of thrombolytic therapy was noted in patients admitted during the registry time (20 [64.5%] vs. 3 [37.5%], P = 0.166). The registry had also significant impact on length of hospital stay (6.72 ± 4.39 days versus 9.35 ± 5.55, P = 0.001, in prospective and retrospective arms, respectively). No significant difference was detected on the 6-month all-cause mortality. However, re-venous thromboembolism was significantly reduced during registry time (2 [1.2%) vs. 22 [12.2%], P < 0.001). Finally, significantly more patients underwent guideline-recommended follow-up during the registry time (107 [72.3%] vs. 30 [16.5%], P < 0.001). Conclusion: Our study showed the implementation of registry had significant effect on PE-related outcome and might have direct impact on burden of pulmonary emboli on the healthcare system.
背景:肺栓塞(PE)是一个主要的公共卫生问题,死亡率相当高。在本研究中,我们评估了注册中心实施对PE管理的影响。方法:在目前由两个不同队列组成的单中心研究中,我们评估了注册实施(2015年9月至2018年8月的前瞻性研究组)对患者管理和生存率的影响,并将其与没有注册的相同持续时间(2012年9月到2015年8月)进行了比较。结果:前瞻性组和回顾性组分别招募了170名和182名患者。在引入PE登记之前,指南建议的风险分层被显著忽视(前瞻性和回顾性组分别为100%和45.6%[P<0.001])。登记期间入院的患者有更高的溶栓治疗给药趋势(20[64.5%]对3[37.5%],P=0.166)住院时间(前瞻性和回顾性组分别为6.72±4.39天和9.35±5.55天,P=0.001)。6个月全因死亡率无显著差异。然而,再静脉血栓栓塞症在登记期间显著减少(2[1.2%vs.22[12.2%],P<0.001),在注册时间内,有更多的患者接受了指南建议的随访(107[72.3%]vs.30[116.5%],P<0.001)。结论:我们的研究表明,注册的实施对PE相关结果有显著影响,并可能对医疗系统的肺栓塞负担产生直接影响。
{"title":"Impact of registry implementation on the management and survival of patients with pulmonary embolism","authors":"O. Shafe, J. Moosavi, A. Alizadehasl, H. Pouraliakbar, B. Naghavi, Sepehr Jamalkhani, Sajjad Rezaei, K. Rezaei-Kalantari, Melody Farrashi, M. Naghshbandi, Parham Rabiei, M. Maleki, H. Talakoob, Maryam Salehi, M. Malakouti, Parham Sadeghipour","doi":"10.4103/rcm.rcm_4_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_4_21","url":null,"abstract":"Background: Pulmonary embolism (PE) is a major public health concern, with a considerable mortality rate. In the present study, we have evaluated the impact of registry implementation on PE management. Methods: In the present single-center study, composed of two distinct cohorts, we have evaluated the impact of registry implementation (prospective arm-September 2015 to August 2018) on patient management and survival, and compared it with the same duration when no registry was implied (retrospective arm-September 2012 to August 2015). Results: One hundred and seventy and 182 patients were recruited in the prospective and retrospective arms, respectively. Guideline-recommended risk stratification was significantly overlooked before the introduction of PE registry (100% vs. 45.6% prospective and retrospective arms, respectively [P < 0.001]). A trend toward higher administration of thrombolytic therapy was noted in patients admitted during the registry time (20 [64.5%] vs. 3 [37.5%], P = 0.166). The registry had also significant impact on length of hospital stay (6.72 ± 4.39 days versus 9.35 ± 5.55, P = 0.001, in prospective and retrospective arms, respectively). No significant difference was detected on the 6-month all-cause mortality. However, re-venous thromboembolism was significantly reduced during registry time (2 [1.2%) vs. 22 [12.2%], P < 0.001). Finally, significantly more patients underwent guideline-recommended follow-up during the registry time (107 [72.3%] vs. 30 [16.5%], P < 0.001). Conclusion: Our study showed the implementation of registry had significant effect on PE-related outcome and might have direct impact on burden of pulmonary emboli on the healthcare system.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"40 - 44"},"PeriodicalIF":0.3,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45359602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The preliminary diagnostic and therapeutic outcomes of chronic thromboembolic pulmonary hypertension registry rajaie cardiovascular medical and research center 慢性血栓栓塞性肺动脉高压的初步诊断和治疗结果
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-04-01 DOI: 10.4103/rcm.rcm_6_21
S. Taghavi, Parham Sadeghipour, S. Amini, Samira Arami, N. Naderi, A. Amin, H. Pouraliakbar, A. Alizadehasl, O. Shafe, J. Moosavi, A. Ghavidel, B. Mohebbi, Ziae Totonchi, R. Azarfarin, H. Sadeghi, M. Mirdamadi, H. Malek, K. Rezaei-Kalantari
Introduction: We herein present the preliminary results of our center's chronic thromboembolic pulmonary hypertension (CTEPH) registry of the tertiary outcomes of patients diagnosed with CTEPH and treated with pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA), or medical treatment. Methods: The present retrospective cross-sectional study was conducted on patients who received treatment for CTEPH in Rajaie Cardiovascular Medical and Research Center over the past four years, from 2016 to 2020. The data were obtained from routine hospital admission and outpatient visit records. The patients were divided into PEA, BPA, and medical treatment groups, and the outcomes and complications of the procedures were reported. Results: Twenty-eight patients, at a median age of 40 (33–59) years were included in our study and were followed for approximately 20.0 (16.2–23.7) months. PEA was performed on 13 (46%) patients, BPA on 10 (35%), and medical therapy only on 5 (17%). Death occurred in 4 (30%) patients after surgery, and 10 (77%) had a surgical complication. There were no deaths or recorded complications in the other two groups, but the rates of postprocedural pulmonary hypertension (30% vs. 91%; P = 0.006) and rehospitalization (7% vs. 73%; P < 0.001) were significantly lower in the operated patients. The 1-year survival rate among the entire study population was 85.7%. Conclusions: The possibility of CTEPH incidence, especially in high-risk patients with dyspnea, should always be borne in mind given its large morbidity and mortality rate and its chances of curability with early diagnosis and proper treatment.
在此,我们报告了本中心慢性血栓栓塞性肺动脉高压(CTEPH)患者的三级结局登记的初步结果,这些患者被诊断为CTEPH并接受肺动脉内膜切除术(PEA)、球囊肺血管成形术(BPA)或药物治疗。方法:回顾性横断面研究2016 - 2020年4年间Rajaie心血管医学研究中心接受CTEPH治疗的患者。数据来自常规住院和门诊就诊记录。将患者分为PEA组、BPA组和药物治疗组,并报告手术结果和并发症。结果:我们的研究纳入了28例患者,中位年龄为40(33-59)岁,随访时间约20.0(16.2-23.7)个月。PEA治疗13例(46%),BPA治疗10例(35%),药物治疗5例(17%)。术后死亡4例(30%),手术并发症10例(77%)。其他两组无死亡或并发症,但术后肺动脉高压发生率(30% vs 91%;P = 0.006)和再住院(7% vs. 73%;P < 0.001)明显低于手术组。整个研究人群的1年生存率为85.7%。结论:考虑到CTEPH的高发病率和死亡率,以及早期诊断和适当治疗的治愈机会,应始终牢记其发生的可能性,特别是在呼吸困难的高危患者中。
{"title":"The preliminary diagnostic and therapeutic outcomes of chronic thromboembolic pulmonary hypertension registry rajaie cardiovascular medical and research center","authors":"S. Taghavi, Parham Sadeghipour, S. Amini, Samira Arami, N. Naderi, A. Amin, H. Pouraliakbar, A. Alizadehasl, O. Shafe, J. Moosavi, A. Ghavidel, B. Mohebbi, Ziae Totonchi, R. Azarfarin, H. Sadeghi, M. Mirdamadi, H. Malek, K. Rezaei-Kalantari","doi":"10.4103/rcm.rcm_6_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_6_21","url":null,"abstract":"Introduction: We herein present the preliminary results of our center's chronic thromboembolic pulmonary hypertension (CTEPH) registry of the tertiary outcomes of patients diagnosed with CTEPH and treated with pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA), or medical treatment. Methods: The present retrospective cross-sectional study was conducted on patients who received treatment for CTEPH in Rajaie Cardiovascular Medical and Research Center over the past four years, from 2016 to 2020. The data were obtained from routine hospital admission and outpatient visit records. The patients were divided into PEA, BPA, and medical treatment groups, and the outcomes and complications of the procedures were reported. Results: Twenty-eight patients, at a median age of 40 (33–59) years were included in our study and were followed for approximately 20.0 (16.2–23.7) months. PEA was performed on 13 (46%) patients, BPA on 10 (35%), and medical therapy only on 5 (17%). Death occurred in 4 (30%) patients after surgery, and 10 (77%) had a surgical complication. There were no deaths or recorded complications in the other two groups, but the rates of postprocedural pulmonary hypertension (30% vs. 91%; P = 0.006) and rehospitalization (7% vs. 73%; P < 0.001) were significantly lower in the operated patients. The 1-year survival rate among the entire study population was 85.7%. Conclusions: The possibility of CTEPH incidence, especially in high-risk patients with dyspnea, should always be borne in mind given its large morbidity and mortality rate and its chances of curability with early diagnosis and proper treatment.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"29 - 36"},"PeriodicalIF":0.3,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46187978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does myocardial injury rapidly progress in marfan syndrome following COVID-19? COVID-19后马凡氏综合征心肌损伤进展迅速吗?
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-04-01 DOI: 10.4103/rcm.rcm_10_21
Z. Khajali, N. Naderi, M. Mirtajaddini, N. Rezaeian
Marfan syndrome is a connective tissue disorder which involves various systems such as the cardiovascular system. One of the cardiovascular manifestations of Marfan syndrome is ventricular dysfunction. In this report, a case of Marfan syndrome was presented who suffered from acute heart failure due to Coronavirus disease 2019 (COVID-19). We discussed about several reasons of heart failure in this case and we suggested that COVID-19 related cardiovascular complications may be more prevalent in Marfan syndrome.
马凡氏综合征是一种结缔组织疾病,涉及多种系统,如心血管系统。马凡氏综合征的心血管表现之一是心室功能障碍。本文报道1例马凡氏综合征患者因新型冠状病毒病(COVID-19)导致急性心力衰竭。我们讨论了本病例心力衰竭的几个原因,我们认为与COVID-19相关的心血管并发症可能在马凡氏综合征中更为普遍。
{"title":"Does myocardial injury rapidly progress in marfan syndrome following COVID-19?","authors":"Z. Khajali, N. Naderi, M. Mirtajaddini, N. Rezaeian","doi":"10.4103/rcm.rcm_10_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_10_21","url":null,"abstract":"Marfan syndrome is a connective tissue disorder which involves various systems such as the cardiovascular system. One of the cardiovascular manifestations of Marfan syndrome is ventricular dysfunction. In this report, a case of Marfan syndrome was presented who suffered from acute heart failure due to Coronavirus disease 2019 (COVID-19). We discussed about several reasons of heart failure in this case and we suggested that COVID-19 related cardiovascular complications may be more prevalent in Marfan syndrome.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"59 - 61"},"PeriodicalIF":0.3,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48735725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of basic cycle length stimuli on effective refractory period measurement 基本周期长度刺激对有效不应期测量的影响
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-04-01 DOI: 10.4103/rcm.rcm_1_21
Mohammd Sadr-Ameli, Farzad Kamali, Milad Vahedinezhad, Sadaf Sadrameli
Background: Refractory periods are measured by the extrastimulus technique, whereby a single extrastimulus is introduced at progressively shorter coupling intervals until a response is no longer elicited. Purpose: As refractoriness of cardiac tissues depends on prior cycle length, refractory periods should be determined at a fixed cycle length within the physiologic range. The extrastimulus is delivered after a train of 8 to 10 paced complexes to allow time for reasonable stabilization of refractoriness, which is usually accomplished after the first 3 or 4 paced beats. Objectives: We conducted this study to compare the effect of 6 vs 8 stimuli in basic cycle length (BCL) in measurement of effective refractory period (ERP). Materials and Methods: During electrophysiologic study (EPS) of 100 consecutive patients, anterograde and retrograde ERP of atrioventricular node (AVN) were measured by introduction of 6 vs 8 stimuli in BCL and premature beat, then the results were compared. Results: Recorded anterograde and retrograde ERP of AVN applying 6 vs 8 stimuli in BCL were compared and no difference was detected. Conclusion: We concluded that for ERP measurement of AVN, 6 stimuli in BCL is comparable to 8 stimuli in reaching the steady state.
背景:不应期是通过外刺激技术来测量的,即以逐渐缩短的耦合间隔引入单个外刺激,直到不再引发反应。目的:由于心脏组织的不应期取决于先前的周期长度,因此应在生理范围内以固定的周期长度确定不应期。额外刺激是在一系列8到10个节奏的复合物之后进行的,以留出时间合理稳定不应性,这通常在前3或4个节奏的节拍之后完成。目的:我们进行了这项研究,比较6和8种基本周期长度刺激(BCL)在测量有效不应期(ERP)方面的效果。材料与方法:在连续100例患者的电生理研究中,通过在BCL和早搏中引入6和8种刺激来测量房室结(AVN)的顺行和逆行ERP,并将结果进行比较。结果:对BCL中应用6和8种刺激记录的AVN顺行和逆行ERP进行比较,没有发现差异。结论:对于AVN的ERP测量,BCL中的6个刺激与8个刺激在达到稳态方面相当。
{"title":"The effect of basic cycle length stimuli on effective refractory period measurement","authors":"Mohammd Sadr-Ameli, Farzad Kamali, Milad Vahedinezhad, Sadaf Sadrameli","doi":"10.4103/rcm.rcm_1_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_1_21","url":null,"abstract":"Background: Refractory periods are measured by the extrastimulus technique, whereby a single extrastimulus is introduced at progressively shorter coupling intervals until a response is no longer elicited. Purpose: As refractoriness of cardiac tissues depends on prior cycle length, refractory periods should be determined at a fixed cycle length within the physiologic range. The extrastimulus is delivered after a train of 8 to 10 paced complexes to allow time for reasonable stabilization of refractoriness, which is usually accomplished after the first 3 or 4 paced beats. Objectives: We conducted this study to compare the effect of 6 vs 8 stimuli in basic cycle length (BCL) in measurement of effective refractory period (ERP). Materials and Methods: During electrophysiologic study (EPS) of 100 consecutive patients, anterograde and retrograde ERP of atrioventricular node (AVN) were measured by introduction of 6 vs 8 stimuli in BCL and premature beat, then the results were compared. Results: Recorded anterograde and retrograde ERP of AVN applying 6 vs 8 stimuli in BCL were compared and no difference was detected. Conclusion: We concluded that for ERP measurement of AVN, 6 stimuli in BCL is comparable to 8 stimuli in reaching the steady state.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"37 - 39"},"PeriodicalIF":0.3,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46964551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Normal values of echocardiographic parameters and incidence of valvular heart findings in 2229 iranian peaple: Results from the “HAMRAH survey” 2229例伊朗人超声心动图参数正常值及瓣膜性心脏的发生率:来自HAMRAH调查的结果
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-04-01 DOI: 10.4103/rcm.rcm_18_21
A. Alizadehasl, H. Bakhshandeh, Parham Sadeghipour, B. Mohebbi, M. Baay, M. Alemzadeh-Ansari, Zahra Hosseini, Z. Norouzi, M. Maleki, F. Noohi, Yasaman Khalili, N. Naderi, H. Pouraliakbar, B. Ghadrdoost, M. Arabian, Shiva Khaleghparast, S. Boudagh
Introduction: It is crucial to define the normal ranges of echocardiographic parameters and their relationships with age, sex, race, and geographical differences given the failure of the existing literature to reflect the diversity of the world's populations. This study aimed to determine the normal ranges of echocardiographic systolic and diastolic values and the incidence of valvular heart lesions with or without rheumatic involvement in a sample of Iranian population. Methods: The Echocardiography Heart Assessment and Monitoring in Rajaie Hospital study is a population-based investigation conducted in Rajaie Cardiovascular Medical and Research Center. A total of 2229 Iranian individuals between 30 and 75 years of age without clinical cardiovascular diseases were invited through a multistage random sampling process, and they underwent two-dimensional and Doppler echocardiography. The left ventricular (LV) ejection fraction, the interventricular septal thickness, the ascending aortic size, the LV diastolic function, the valvular heart disease (VHD) severity, and rheumatic valvular involvement were assessed. Results: The study population comprised 2229 patients: 882 men (40%) and 1347 women (60%) at an age range of 39–58 years and a mean age of 48 years. The average body mass index was 28.8 kg/m2 (25.9–32 kg/m2), and the median body surface area was 1.86. Mildsystolic dysfunction was reported in 119 patients (5.7%) and moderate systolic dysfunction in 19 (0.9%). LV systolic dysfunction was significantly correlated with the male sex, age, and hypertension (P < 0.001). The mean interventricular septal thickness was 8 mm. Mild LV hypertrophy (LVH) was detected in 5.5% of all the patients and moderate LVH in 0.4%. The mean interventricular septal thickness significantly increased with age (P < 0.001), and it was higher in the men than in the women (8.2 mm [7.8–9.2] vs. 8 mm [7–8.25]; P < 0.001). Mild LVH and moderate LVH were significantly correlated with hypertension, diabetes mellitus, hyperlipidemia, chronic kidney disease, and diastolic dysfunction (P < 0.001). Diastolic dysfunction was found in 29% of the patients (28.6% mild and 0.2% moderate). Significant correlations were found between LV diastolic dysfunction and age, the female sex, diabetes mellitus, hypertension, hyperlipidemia, and hypercholesterolemia (P < 0.001). The mean ascending aortic size was 31 mm in the men and 29 mm in the women. The ascending aortic size exceeded 37 mm in 5% of the men and 3.5% of the women. The indexed ascending aortic size was 1.54 cm/m2 in the men and 1.66 cm/m2 in the women. Valvular heart lesions were diagnosed in about half of the study population. The most common findings were mild regurgitation in the mitral and tricuspid valves. Multiple valvular disorders were found in 55% of the patients. Among significant (moderate and more-than-moderate) VHDs, tricuspid regurgitation (36%), mitral regurgitation (33%), and aortic regurgitation (19%) were the most f
引言:鉴于现有文献未能反映世界人口的多样性,确定超声心动图参数的正常范围及其与年龄、性别、种族和地理差异的关系至关重要。本研究旨在确定伊朗人群中超声心动图收缩期和舒张期值的正常范围以及有或无风湿病累及的瓣膜性心脏病变的发生率。方法:拉加伊医院超声心动图心脏评估与监测研究是在拉加伊心血管医学研究中心开展的一项基于人群的调查。通过多阶段随机抽样,共邀请2229名年龄在30至75岁之间、无临床心血管疾病的伊朗人接受二维和多普勒超声心动图检查。评估左室(LV)射血分数、室间隔厚度、升主动脉大小、左室舒张功能、瓣膜性心脏病(VHD)严重程度和风湿性瓣膜受累。结果:研究人群包括2229例患者:男性882例(40%),女性1347例(60%),年龄39-58岁,平均年龄48岁。平均体重指数为28.8 kg/m2 (25.9 ~ 32 kg/m2),中位体表面积为1.86。轻度收缩功能障碍119例(5.7%),中度收缩功能障碍19例(0.9%)。左室收缩功能障碍与男性、年龄、高血压显著相关(P < 0.001)。室间隔平均厚度为8mm。5.5%的患者有轻度左室肥厚,0.4%的患者有中度左室肥厚。室间隔平均厚度随年龄增加而显著增高(P < 0.001),且男性高于女性(8.2 mm [7.8 ~ 9.2] vs. 8 mm [7 ~ 8.25];P < 0.001)。轻度LVH和中度LVH与高血压、糖尿病、高脂血症、慢性肾病、舒张功能不全显著相关(P < 0.001)。29%的患者存在舒张功能障碍(28.6%为轻度,0.2%为中度)。左室舒张功能障碍与年龄、女性、糖尿病、高血压、高脂血症、高胆固醇血症有显著相关性(P < 0.001)。男性的平均升主动脉直径为31毫米,女性为29毫米。5%的男性和3.5%的女性升主动脉直径超过37mm。男性的指数升主动脉大小为1.54 cm/m2,女性为1.66 cm/m2。大约一半的研究人群被诊断出心脏瓣膜病变。最常见的表现是二尖瓣和三尖瓣轻度反流。55%的患者存在多重瓣膜疾病。在显著(中度和中度以上)vhd中,三尖瓣反流(36%)、二尖瓣反流(33%)和主动脉反流(19%)是最常见的vhd。31例(1.4%)患者被诊断为风湿性瓣膜受累。结论:超声心动图参数随年龄、性别、种族的不同而不同,应进行人群调整。我们建议在伊朗的不同地区进行进一步的研究,以获得足够的数据,以创建关于超声心动图参数的适用指南。
{"title":"Normal values of echocardiographic parameters and incidence of valvular heart findings in 2229 iranian peaple: Results from the “HAMRAH survey”","authors":"A. Alizadehasl, H. Bakhshandeh, Parham Sadeghipour, B. Mohebbi, M. Baay, M. Alemzadeh-Ansari, Zahra Hosseini, Z. Norouzi, M. Maleki, F. Noohi, Yasaman Khalili, N. Naderi, H. Pouraliakbar, B. Ghadrdoost, M. Arabian, Shiva Khaleghparast, S. Boudagh","doi":"10.4103/rcm.rcm_18_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_18_21","url":null,"abstract":"Introduction: It is crucial to define the normal ranges of echocardiographic parameters and their relationships with age, sex, race, and geographical differences given the failure of the existing literature to reflect the diversity of the world's populations. This study aimed to determine the normal ranges of echocardiographic systolic and diastolic values and the incidence of valvular heart lesions with or without rheumatic involvement in a sample of Iranian population. Methods: The Echocardiography Heart Assessment and Monitoring in Rajaie Hospital study is a population-based investigation conducted in Rajaie Cardiovascular Medical and Research Center. A total of 2229 Iranian individuals between 30 and 75 years of age without clinical cardiovascular diseases were invited through a multistage random sampling process, and they underwent two-dimensional and Doppler echocardiography. The left ventricular (LV) ejection fraction, the interventricular septal thickness, the ascending aortic size, the LV diastolic function, the valvular heart disease (VHD) severity, and rheumatic valvular involvement were assessed. Results: The study population comprised 2229 patients: 882 men (40%) and 1347 women (60%) at an age range of 39–58 years and a mean age of 48 years. The average body mass index was 28.8 kg/m2 (25.9–32 kg/m2), and the median body surface area was 1.86. Mildsystolic dysfunction was reported in 119 patients (5.7%) and moderate systolic dysfunction in 19 (0.9%). LV systolic dysfunction was significantly correlated with the male sex, age, and hypertension (P &lt; 0.001). The mean interventricular septal thickness was 8 mm. Mild LV hypertrophy (LVH) was detected in 5.5% of all the patients and moderate LVH in 0.4%. The mean interventricular septal thickness significantly increased with age (P &lt; 0.001), and it was higher in the men than in the women (8.2 mm [7.8–9.2] vs. 8 mm [7–8.25]; P &lt; 0.001). Mild LVH and moderate LVH were significantly correlated with hypertension, diabetes mellitus, hyperlipidemia, chronic kidney disease, and diastolic dysfunction (P &lt; 0.001). Diastolic dysfunction was found in 29% of the patients (28.6% mild and 0.2% moderate). Significant correlations were found between LV diastolic dysfunction and age, the female sex, diabetes mellitus, hypertension, hyperlipidemia, and hypercholesterolemia (P &lt; 0.001). The mean ascending aortic size was 31 mm in the men and 29 mm in the women. The ascending aortic size exceeded 37 mm in 5% of the men and 3.5% of the women. The indexed ascending aortic size was 1.54 cm/m2 in the men and 1.66 cm/m2 in the women. Valvular heart lesions were diagnosed in about half of the study population. The most common findings were mild regurgitation in the mitral and tricuspid valves. Multiple valvular disorders were found in 55% of the patients. Among significant (moderate and more-than-moderate) VHDs, tricuspid regurgitation (36%), mitral regurgitation (33%), and aortic regurgitation (19%) were the most f","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"45 - 53"},"PeriodicalIF":0.3,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42716818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the diagnosis of cardiac amyloidosis in a patient with large pericardial effusion and tamponade 揭示一例大量心包积液和心包填塞的心脏淀粉样变的诊断
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-04-01 DOI: 10.4103/rcm.rcm_3_21
Pardha Sivakoti, G. Harsha, Praveen Nagula, Srinivas Ravi
Amyloidosis is a clinical disorder caused by extracellular deposition of insoluble fibrils with beta-pleated sheet configuration. The protein misfolding abnormalities result in amyloid fibrils and may manifest as primary, secondary, familial, or senile amyloidosis. Amyloid deposition can occur in multiple organs (e.g. heart, liver, kidney, skin, eyes, lungs, and nervous system), resulting in a variety of clinical manifestations. Cardiac involvement is a progressive disorder resulting in early death due to congestive heart failure and arrhythmias. We report a rare case of cardiac amyloidosis presenting as recurrent pericardial effusion with features of restrictive cardiomyopathy.
淀粉样变性是一种临床疾病,由细胞外沉积的不溶性原纤维与β -褶片状结构引起。蛋白质错误折叠异常导致淀粉样蛋白原纤维,可表现为原发性、继发性、家族性或老年性淀粉样变性。淀粉样蛋白沉积可发生在多个器官(如心、肝、肾、皮肤、眼睛、肺和神经系统),导致多种临床表现。心脏受累是一种进行性疾病,由于充血性心力衰竭和心律失常导致早期死亡。我们报告一个罕见的心脏淀粉样变病例,表现为复发性心包积液,并具有限制性心肌病的特征。
{"title":"Unveiling the diagnosis of cardiac amyloidosis in a patient with large pericardial effusion and tamponade","authors":"Pardha Sivakoti, G. Harsha, Praveen Nagula, Srinivas Ravi","doi":"10.4103/rcm.rcm_3_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_3_21","url":null,"abstract":"Amyloidosis is a clinical disorder caused by extracellular deposition of insoluble fibrils with beta-pleated sheet configuration. The protein misfolding abnormalities result in amyloid fibrils and may manifest as primary, secondary, familial, or senile amyloidosis. Amyloid deposition can occur in multiple organs (e.g. heart, liver, kidney, skin, eyes, lungs, and nervous system), resulting in a variety of clinical manifestations. Cardiac involvement is a progressive disorder resulting in early death due to congestive heart failure and arrhythmias. We report a rare case of cardiac amyloidosis presenting as recurrent pericardial effusion with features of restrictive cardiomyopathy.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"65 - 67"},"PeriodicalIF":0.3,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47923472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute provoked pulmonary embolism masquerading as inferior wall myocardial infarction with right ventricular infarction 伪装成下壁心肌梗死合并右心室梗死的急性肺栓塞
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-04-01 DOI: 10.4103/rcm.rcm_32_21
Tutan Das, D. Das, D. Acharya, S. Singh, J. Gupta, Subhash R. Pramanik
We present an extreme rare case of acute pulmonary embolism in an 83-year-old male presenting as acute inferior wall ST-elevated myocardial infarction with right ventricular infarction (RVMI) in electrocardiogram (ECG). Acute pulmonary embolism presenting as acute inferior wall ST-elevation myocardial infarction with RVMI has not been described in the world literature so far. Our case is unique and first to describe the presentation of acute pulmonary embolism in the form of inferior wall ST-elevated myocardial infarction with evidence of RVMI in the ECG. It is of utmost important for the treating cardiologist and critical care physician to differentiate the same as treatment modalities of both conditions varies markedly and wrong therapeutic measures can land up in a catastrophe.
我们报告了一例极为罕见的急性肺栓塞病例,患者为83岁男性,心电图表现为急性下壁ST段抬高型心肌梗死伴右心室梗死(RVMI)。急性肺栓塞表现为急性下壁ST段抬高心肌梗死伴右室心肌梗死,迄今为止,世界文献中尚未描述。我们的病例是独特的,并且首次描述了以下壁ST段抬高心肌梗死形式出现的急性肺栓塞,心电图中有RVMI的证据。对于治疗心脏病的专家和重症监护医生来说,区分相同的情况至关重要,因为这两种情况的治疗方式差异很大,错误的治疗措施可能会导致灾难。
{"title":"Acute provoked pulmonary embolism masquerading as inferior wall myocardial infarction with right ventricular infarction","authors":"Tutan Das, D. Das, D. Acharya, S. Singh, J. Gupta, Subhash R. Pramanik","doi":"10.4103/rcm.rcm_32_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_32_21","url":null,"abstract":"We present an extreme rare case of acute pulmonary embolism in an 83-year-old male presenting as acute inferior wall ST-elevated myocardial infarction with right ventricular infarction (RVMI) in electrocardiogram (ECG). Acute pulmonary embolism presenting as acute inferior wall ST-elevation myocardial infarction with RVMI has not been described in the world literature so far. Our case is unique and first to describe the presentation of acute pulmonary embolism in the form of inferior wall ST-elevated myocardial infarction with evidence of RVMI in the ECG. It is of utmost important for the treating cardiologist and critical care physician to differentiate the same as treatment modalities of both conditions varies markedly and wrong therapeutic measures can land up in a catastrophe.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"68 - 71"},"PeriodicalIF":0.3,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49245585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electrocardiogram predictors of multivessel disease in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 经皮冠状动脉介入治疗ST段抬高型心肌梗死患者多血管病变的心电图预测因素
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-01-01 DOI: 10.4103/rcm.rcm_42_20
A. Sharma, Tarun Kumar, M. Dhaka
Objective: The objective was to study the role of 12-lead electrocardiogram (ECG) changes in predicting the association of severe stenosis of other coronary arteries along with infarct-related artery in patients who presented with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Materials and Methods: We studied the admission ECG, clinical records, and coronary angiography of 201 patients with STEMI who underwent primary PCI within the first 12 h of symptoms. Patients with first episode of STEMI and coronary angiogram showing coronary artery disease between January 2015 and July 2016 were included in this study. Results: Most of the patients in this study were males (82.1%). The mean age of the patients was 55.20 ± 11.79 years. Diabetic mellitus (37.8%), hypertension (37%), and smoking (49.7%) were the main risk factors. This study had 117 (58.2%) patients of anterior wall myocardial infarction (MI) (Group I) while inferior wall MI was present in 84 (41.8%) patients (Group II). In Group I, 83 (70.9%) patients had single-vessel disease (SVD) while 34 (29.1%) patients had multivessel disease (MVD). The presence of ST-segment depression ≥0.1 mV in leads I, aVL, and V6 significantly correlated with the presence of MVD (P = 0.001, 0.001, and 0.001, respectively). In Group II, 39 (51.3%) patients had SVD while 37 (48.7%) patients had MVD. The presence of ST-segment depression in leads aVL, V5, and V6 significantly correlated with the presence of MVD (P = 0.049, 0.001, and 0.001, respectively). Conclusion: The presence of ST-segment depression of ≥0.1 mv in leads I, aVL, and V6 on admission ECG in the setting of acute anterior wall STEMI and in leads aVL, V5, and V6 on admission ECG in the setting of acute inferior wall STEMI was associated with MVD.
目的:目的是研究12导联心电图(ECG)变化在预测st段抬高型心肌梗死(STEMI)患者接受初级经皮冠状动脉介入治疗(PCI)时其他冠状动脉和梗死相关动脉严重狭窄的相关性中的作用。材料与方法:我们对201例STEMI患者在出现症状的最初12小时内行首次PCI的入院心电图、临床记录和冠状动脉造影进行了研究。2015年1月至2016年7月期间首次STEMI发作并冠状动脉造影显示冠心病的患者纳入本研究。结果:本组患者以男性居多(82.1%)。患者平均年龄55.20±11.79岁。糖尿病(37.8%)、高血压(37%)和吸烟(49.7%)是主要危险因素。本研究有117例(58.2%)前壁心肌梗死(MI) (I组),84例(41.8%)下壁心肌梗死(II组)。在I组中,83例(70.9%)为单血管疾病(SVD), 34例(29.1%)为多血管疾病(MVD)。I导联、aVL导联和V6导联st段压低≥0.1 mV与MVD存在显著相关(P分别为0.001、0.001和0.001)。II组39例(51.3%)有SVD, 37例(48.7%)有MVD。aVL、V5和V6导联st段凹陷与MVD存在显著相关(P分别为0.049、0.001和0.001)。结论:急性前壁STEMI入院时I、aVL、V6导联st段下降≥0.1 mv,急性下壁STEMI入院时aVL、V5、V6导联st段下降≥0.1 mv与MVD相关。
{"title":"Electrocardiogram predictors of multivessel disease in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention","authors":"A. Sharma, Tarun Kumar, M. Dhaka","doi":"10.4103/rcm.rcm_42_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_42_20","url":null,"abstract":"Objective: The objective was to study the role of 12-lead electrocardiogram (ECG) changes in predicting the association of severe stenosis of other coronary arteries along with infarct-related artery in patients who presented with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Materials and Methods: We studied the admission ECG, clinical records, and coronary angiography of 201 patients with STEMI who underwent primary PCI within the first 12 h of symptoms. Patients with first episode of STEMI and coronary angiogram showing coronary artery disease between January 2015 and July 2016 were included in this study. Results: Most of the patients in this study were males (82.1%). The mean age of the patients was 55.20 ± 11.79 years. Diabetic mellitus (37.8%), hypertension (37%), and smoking (49.7%) were the main risk factors. This study had 117 (58.2%) patients of anterior wall myocardial infarction (MI) (Group I) while inferior wall MI was present in 84 (41.8%) patients (Group II). In Group I, 83 (70.9%) patients had single-vessel disease (SVD) while 34 (29.1%) patients had multivessel disease (MVD). The presence of ST-segment depression ≥0.1 mV in leads I, aVL, and V6 significantly correlated with the presence of MVD (P = 0.001, 0.001, and 0.001, respectively). In Group II, 39 (51.3%) patients had SVD while 37 (48.7%) patients had MVD. The presence of ST-segment depression in leads aVL, V5, and V6 significantly correlated with the presence of MVD (P = 0.049, 0.001, and 0.001, respectively). Conclusion: The presence of ST-segment depression of ≥0.1 mv in leads I, aVL, and V6 on admission ECG in the setting of acute anterior wall STEMI and in leads aVL, V5, and V6 on admission ECG in the setting of acute inferior wall STEMI was associated with MVD.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"1 - 6"},"PeriodicalIF":0.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44093998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-vessel coronary artery dissection in a patient with congenital aortopathy 一例先天性主动脉病变患者的多血管冠状动脉夹层
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-01-01 DOI: 10.4103/rcm.rcm_46_20
A. Fakhrabadi, M. Zanganehfar, S. Saedi, M. Maleki, M. Ansari, H. Pouraliakbar
Spontaneous coronary artery dissection (SCAD) is a well-documented cause of acute coronary syndrome and could have life-threatening consequences. We report the case of young female with a prior history of cardiac surgery due to congenital aortic stenosis presenting with multi-vessel SCAD. She was successfully managed with medical treatment.
自发性冠状动脉剥离(SCAD)是一个有充分证据的急性冠状动脉综合征的原因,可能会危及生命的后果。我们报告的情况下,年轻女性有心脏手术史,由于先天性主动脉狭窄,目前多血管SCAD。她通过药物治疗得到了成功的控制。
{"title":"Multi-vessel coronary artery dissection in a patient with congenital aortopathy","authors":"A. Fakhrabadi, M. Zanganehfar, S. Saedi, M. Maleki, M. Ansari, H. Pouraliakbar","doi":"10.4103/rcm.rcm_46_20","DOIUrl":"https://doi.org/10.4103/rcm.rcm_46_20","url":null,"abstract":"Spontaneous coronary artery dissection (SCAD) is a well-documented cause of acute coronary syndrome and could have life-threatening consequences. We report the case of young female with a prior history of cardiac surgery due to congenital aortic stenosis presenting with multi-vessel SCAD. She was successfully managed with medical treatment.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"23 - 25"},"PeriodicalIF":0.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48305870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple recurrences in a nonfamilial cardiac myxoma 非家族性心脏黏液瘤多发复发
IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2021-01-01 DOI: 10.4103/rcm.rcm_7_21
R. Salehi, M. Mirtajaddini, M. Chenaghlou, Leili Faridi
Cardiac myxomas are the most common primary cardiac tumors, with an estimated incidence of 0.5 per million individuals annually. Although surgical resection is curative however, postoperative tumor recurrence has been reported, especially in familial and complex type of myxoma. Literature reviews reveal only a few cases of recurrence in sporadic cardiac myxoma. Herein we have reported a case of sporadic cardiac myxoma, with multiple recurrences after surgical resection. The possibility of repeated recurrence of cardiac myxomas demonstrates the importance of regular echocardiographic surveillance after surgical resection in order to detection of recurrence even in non-familial and non-syndromic cases. Further evaluations, including genetic analysis of patients with recurrent cardiac myxomas, are warranted to investigate the exact nature of these tumors.
心脏粘液瘤是最常见的原发性心脏肿瘤,估计每年发病率为百万分之0.5。尽管手术切除是可以治愈的,但术后肿瘤复发的报道也有,尤其是在家族性和复杂型粘液瘤中。文献综述显示只有少数病例复发的散发性心脏粘液瘤。本文报告一例散发性心脏粘液瘤,手术切除后多次复发。心脏粘液瘤反复复发的可能性表明,即使在非家族性和非综合征病例中,手术切除后定期超声心动图监测对于检测复发也很重要。进一步的评估,包括对复发性心脏粘液瘤患者的基因分析,有必要研究这些肿瘤的确切性质。
{"title":"Multiple recurrences in a nonfamilial cardiac myxoma","authors":"R. Salehi, M. Mirtajaddini, M. Chenaghlou, Leili Faridi","doi":"10.4103/rcm.rcm_7_21","DOIUrl":"https://doi.org/10.4103/rcm.rcm_7_21","url":null,"abstract":"Cardiac myxomas are the most common primary cardiac tumors, with an estimated incidence of 0.5 per million individuals annually. Although surgical resection is curative however, postoperative tumor recurrence has been reported, especially in familial and complex type of myxoma. Literature reviews reveal only a few cases of recurrence in sporadic cardiac myxoma. Herein we have reported a case of sporadic cardiac myxoma, with multiple recurrences after surgical resection. The possibility of repeated recurrence of cardiac myxomas demonstrates the importance of regular echocardiographic surveillance after surgical resection in order to detection of recurrence even in non-familial and non-syndromic cases. Further evaluations, including genetic analysis of patients with recurrent cardiac myxomas, are warranted to investigate the exact nature of these tumors.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"10 1","pages":"26 - 28"},"PeriodicalIF":0.3,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42792359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Research in Cardiovascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1